Pfizer is considering a full or partial sale of its consumer healthcare business. The business had 2016 revenues of approximately $3.4 billion and includes two top-selling consumer healthcare brands (Centrum and Advil). Read More

FDA Commissioner Scott Gottlieb updated the agency’s efforts to track the impact on drug manufacturing in Puerto Rico following Hurricanes Irma and Maria. The FDA estimates that 40 pharmaceutical and biological drug products may be subject to shortages due to manufacturing interruptions. Read More

Janssen Sciences Ireland UC, part of Johnson & Johnson, is investing more than EUR 300 million ($354 million) to expand its biomanufacturing facility in Ringaskiddy, County Cork, Ireland. The expansion is expected to take around two years to complete and begins in October 2017. Read More

The FDA has issued a Complete Response Letter (CRL) to Mylan and Biocon, a Bangalore, India-based pharmaceutical company, for their biologics license application for a proposed biosimilar to Amgen’s top-selling drug, Neulasta (pegfilgrastim), which is used to stimulate white blood cell production after chemotherapy. Read More

California Governor Edmund G. Brown Jr. has signed legislation, Senate Bill 17,  Healthcare: Prescription Drug Costs , to increase transparency in prescription drug pricing by requiring pharmaceutical companies to give notice before raising prices by certain levels. Read More

Piramal Pharma Solutions, a CDMO, is investing $55 million across its sites in North America and Asia to expand its active pharmaceutical ingredient manufacturing capabilities and capacities. Read More

Xellia Pharmaceuticals, a specialty pharmaceutical company focused on anti-infectives, has broken ground on a new $25-million facility for sterile manufacturing in Copenhagen. Read More

Eli Lilly and Company has won a victory in litigation initiated by Novartis’ generic arm, Sandoz, and Neptune Generics, a specialty and generics pharmaceutical company, regarding patentability of Lilly’s vitamin regimen for Alimta (pemetrexed), a lung cancer drug, with 2016 sales of $2.3 billion. Read More

The European Medicines Agency (EMA) has published information about its assessment of the 19 member states’ bids to host the London-based agency, which is being relocated in the wake of the UK’s decision to exit the European Union. Read More

CordenPharma, a CDMO of drug substances and drug products, has agreed to acquire an active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colorado from Hospira, a Pfizer company. The transaction is expected to close in November 2017. Read More